Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
11/23/2011 | EP1937259B1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
11/23/2011 | EP1864659B1 Lignane compound-containing oil-in-water emulsion and composition comprising the same |
11/23/2011 | EP1852433B1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
11/23/2011 | EP1802571B1 Method and intermediates for the preparation of derivatives of n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulphonamide |
11/23/2011 | EP1735277B1 2-alkylidene-18,19-dinor-vitamin d compounds |
11/23/2011 | EP1671649B1 Dipeptidyl peptidase IV inhibitors for treating diabetic patients with sulfonylurea secondary failure |
11/23/2011 | EP1633375B1 Combination consisting of a magnesium preparation having a prolonged release and of certain plant extracts, and use thereof in the fields of cosmetics, therapeutics and/or nutrition |
11/23/2011 | EP1589964B1 Compounds having anti-proliferative properties |
11/23/2011 | EP1509541B1 Novel recombinant anticoagulant proteins |
11/23/2011 | EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors |
11/23/2011 | EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
11/23/2011 | EP1362105B1 Anti-interferon-alpha antibodies |
11/23/2011 | EP1087779B1 Compositions for increasing energy in vivo |
11/23/2011 | CN1968921B Glucagon receptor antagonists, preparation and therapeutic uses |
11/23/2011 | CN102257389A Screening method for identifying patients at risk of adverse hepatologic events |
11/23/2011 | CN102256973A Corydaline derivatives useful for reducing lipid levels |
11/23/2011 | CN102256966A Soluble mtor complexes and modulators thereof |
11/23/2011 | CN102256952A Arylcyclopropylacetamide derivatives useful as glucokinase activators |
11/23/2011 | CN102256601A A microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type 1 diabetes mellitus |
11/23/2011 | CN102250935A Recombinant transgenic vector carrying human insulin-like growth factor-I and use thereof |
11/23/2011 | CN102250778A Lachnum sp., extracellular polysaccharide thereof and application of extracellular polysaccharide in lipid-lowering liver-favoring medicaments |
11/23/2011 | CN102250735A Propolis wine combined with golden camellia and preparation method thereof |
11/23/2011 | CN102250734A Linearstripe rabdosia herb combined propolis wine and preparation method thereof |
11/23/2011 | CN102250733A Health-care wine matched with gynostemma pentaphylla and preparation method thereof |
11/23/2011 | CN102250342A PEG/mPEG (Polyethylene Glycol) multi-carboxyl chemical modifying agent connected with citric acid, preparation method and application thereof in modification of toluylene compound |
11/23/2011 | CN102250242A Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
11/23/2011 | CN102250186A Berberine-oryzanol compound, and preparation method and application thereof |
11/23/2011 | CN102250144A Thiazolidone compound and application thereof |
11/23/2011 | CN102250098A Pyrazinones compound |
11/23/2011 | CN102250082A Benzimidazolyl thiazolidinone compounds and synthesis method thereof |
11/23/2011 | CN102250071A Pyrazole compounds useful as protein kinase inhibitors |
11/23/2011 | CN102250064A Glutamic acid derivants |
11/23/2011 | CN102250019A (Thio) barbituric acid compound and application thereof |
11/23/2011 | CN102250006A 3-pyrazole carboxylic acid amide compounds, preparation method thereof and application thereof in preparation of medicament serving as CB1 receptor inhibitor |
11/23/2011 | CN102249981A N-arylsulfonyl-3-aminoalkoxyindoles |
11/23/2011 | CN102249978A KY crystal form of Atorvastatin calcium and preparation method thereof |
11/23/2011 | CN102247572A Medicament for treating hyperlipidemia |
11/23/2011 | CN102247570A Traditional Chinese medicine composition for treating cow ketosis |
11/23/2011 | CN102247542A Medicine for treating diabetes and kidney disease, cataract and other diabetic complications |
11/23/2011 | CN102247541A Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma |
11/23/2011 | CN102247538A Application of gymnadenia conopsea to preparing lipid lowering and liver protecting medicament |
11/23/2011 | CN102247526A Tangniaole capsule and preparation method thereof |
11/23/2011 | CN102247515A Traditional Chinese medicine compound preparation used for treating diabetic nephropathy, and preparation method thereof |
11/23/2011 | CN102247488A Tea polyphenol extraction technology |
11/23/2011 | CN102247483A Scorpion health-care liquor |
11/23/2011 | CN102247451A Sustained release tablet prepared from raw material of hawthorn leave total flavonoids, and preparation method thereof |
11/23/2011 | CN102247420A Preparation method and application of eclipta extract |
11/23/2011 | CN102247417A Fat reduction effect of total saponins and polysaccharides of Panax japonicus |
11/23/2011 | CN102247416A Blood lipid lowering application of total saponins of panax japonicus |
11/23/2011 | CN102247413A Hypolipidemic effects of radix dipsaci total saponin and akebia stem saponin D |
11/23/2011 | CN102247410A Application of fiddlehead flavone extractive in preparing drug capable of lowering blood fat |
11/23/2011 | CN102247402A Method for acticating and stabilizing dissolved hydrogen in water |
11/23/2011 | CN102247400A Blood lipid-reducing effect of panax japonicus polysaccharide |
11/23/2011 | CN102247394A Medical application of Harpagoside ingredient |
11/23/2011 | CN102247391A Application of panax japonicus saponin V to reduction of blood fat |
11/23/2011 | CN102247378A Application of pristimerin in preparing anti-angiogenic medicine |
11/23/2011 | CN102247377A Application of carbon drop quinone methyl triterpene to preparation of drug for preventing and treating diabetes |
11/23/2011 | CN102247373A Composition of methionine vitamin B1 compound |
11/23/2011 | CN102247372A Methionine-containing medicinal composition and preparation method thereof |
11/23/2011 | CN102247370A Compound repaglinide-metformin hydrochloride controlled release preparation |
11/23/2011 | CN102247356A Use of andrographolides |
11/23/2011 | CN102247348A Application of 9-cis-retinoic acid in preparing medicament for treating diabetic skin ulcer |
11/23/2011 | CN102247345A Novel blood lipid lowering composition |
11/23/2011 | CN102247343A Preparation process of compound pioglitazone and metformin sustained-release tablets |
11/23/2011 | CN102247322A Octacosanol micro-emulsion and preparation method thereof |
11/23/2011 | CN102247317A Vitamin c injection and preparation method thereof |
11/23/2011 | CN102246965A Production method of microcapsule containing vitamin F |
11/23/2011 | CN102246871A Traditional Chinese medicine tea |
11/23/2011 | CN102000157B Medicinal liquor with treatment and health-care functions |
11/23/2011 | CN101961460B Chinese medicinal health-care composition and preparation method thereof |
11/23/2011 | CN101878790B Nutrification flour for diabetics and preparation method thereof |
11/23/2011 | CN101785802B Cinnamomum japonicum phenolic compound and preparation method and application thereof |
11/23/2011 | CN101785763B Metformin hydrochloride enteric-coated sustained release tablet and preparation method thereof |
11/23/2011 | CN101766668B Burdock extract and preparation method and application thereof |
11/23/2011 | CN101732366B Medicine with function of treating hypertension, hyperlipoidemia, diabetes and sleep disorder |
11/23/2011 | CN101716213B Traditional Chinese medicine effective fraction composition for detoxification and lipid lowering and preparation method thereof |
11/23/2011 | CN101712726B Method for preparing high-purity mulberry leaf polysaccharide |
11/23/2011 | CN101703617B Medicinal composition for treating diabetic nephropathy and preparation method thereof |
11/23/2011 | CN101675950B A traditional Chinese medicine preparation for treating diabetic nephropathy, and preparation method and application thereof |
11/23/2011 | CN101658489B Nalmefene hydrochloride injection and preparation method thereof |
11/23/2011 | CN101543569B Donkey-hide glue nourishing ointment and preparing method thereof |
11/23/2011 | CN101460159B Fatigue-reducing agent |
11/23/2011 | CN101428078B Tibetan medicine composition for governing blood fat and preparation thereof |
11/23/2011 | CN101361886B Chinese herbal medicine extract with lipase activity inhibition and new use thereof |
11/23/2011 | CN101347495B Preparation of Glabridin dispersible tablets and use of the tablets in reducing blood sugar as medicament active composition |
11/23/2011 | CN101347414B Divisible galenical preparation form capable of controlling release of active ingredient |
11/23/2011 | CN101244202B Chinese medicine oral administration solid preparations, preparation, quality control method and uses thereof |
11/23/2011 | CN101193853B Anthranilic acid derivatives |
11/23/2011 | CN101156908B Application of argentina anserina extractive in preparation of alpha glycosidase enzymes inhibitors |
11/23/2011 | CN101130567B Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
11/22/2011 | US8063081 Aryl carbonyl derivatives as therapeutic agents |
11/22/2011 | US8063079 Cyclopropyl compounds |
11/22/2011 | US8063045 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity |
11/22/2011 | US8063029 Pharmaceutical composition |
11/22/2011 | US8063017 Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products |
11/22/2011 | CA2666090C Use of nicotinic acid adenine dinucleotide phosphate or derivative thereof as agent for treating type-2 diabetes |
11/22/2011 | CA2664720C Vitamin d derivatives |
11/22/2011 | CA2547873C Tetrapeptide regulating blood glucose level in diabetes mellitus |
11/22/2011 | CA2524401C Thiazole derivatives as inhibitors of phosphatidylinositol 3-kinase |
11/22/2011 | CA2502439C Prostaglandin compounds for the treatment of obesity |